{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:21:22Z","timestamp":1792131682758,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Late-onset Alzheimer\u2019s disease (LOAD) is the most common form of dementia in the elderly, yet no curative treatments are available. Although genome-wide association studies (GWASs) have identified numerous genetic risk factors, these factors often differ among ethnic groups, and the mechanisms driving LOAD onset remain poorly understood. Most GWASs of LOAD have been conducted in European populations; the expansion of future studies to non-European populations should uncover novel genetic factors underlying LOAD pathogenesis. To identify novel LOAD-susceptible genes, we conducted whole-genome sequencing data analysis on 1928 Japanese individuals including 325 patients with LOAD and 1603 cognitively normal elderly controls. A GWAS for common variants identified a statistically significant association signal in rs429358, within the apolipoprotein E gene (\n                    <jats:italic>APOE<\/jats:italic>\n                    ), which defines the\n                    <jats:italic>APOE<\/jats:italic>\n                    <jats:inline-formula>\n                      <jats:alternatives>\n                        <jats:tex-math>$$\\varepsilon$$<\/jats:tex-math>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                          <mml:mi>\u03b5<\/mml:mi>\n                        <\/mml:math>\n                      <\/jats:alternatives>\n                    <\/jats:inline-formula>\n                    <jats:italic>4<\/jats:italic>\n                    haplotype. This association was successfully replicated in an independent Japanese replication cohort of 4768 samples, genotyped using the Asian Screening Array. For rare variants, a gene-based association study identified two rare variants, rs769490815 and rs1921732305, in\n                    <jats:italic>Inositol polyphosphate 5-phosphatase<\/jats:italic>\n                    (\n                    <jats:italic>INPP5J<\/jats:italic>\n                    ) as potential candidates for LOAD association. Due to their extremely low allele frequencies, these variants were not included on the genotyping array and could not be evaluated in the replication cohort. However in vitro functional analyses revealed that the ethnicity-specific p.K687T mutation (rs1921732305) significantly reduced the phosphatase activity of INPP5J, suggesting a potential pathogenic role in LOAD.\n                  <\/jats:p>","DOI":"10.1038\/s41398-026-04027-0","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T08:38:43Z","timestamp":1775637523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Whole-genome sequencing reveals an East Asian-specific rare variant of INPP5J associated with Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2010-104X","authenticated-orcid":false,"given":"Tetsuaki","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2255-4418","authenticated-orcid":false,"given":"Akiko","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Mitsumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6192-8035","authenticated-orcid":false,"given":"Shumpei","family":"Niida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0028-1570","authenticated-orcid":false,"given":"Kouichi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4412-0552","authenticated-orcid":false,"given":"Daichi","family":"Shigemizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"4027_CR1","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3390\/ijms24021059","volume":"24","author":"BK Beata","year":"2023","unstructured":"Beata BK, Wojciech J, Johannes K, Piotr L, Barbara M. Alzheimer\u2019s disease-biochemical and psychological background for diagnosis and treatment. Int J Mol Sci. 2023;24:1059.","journal-title":"Int J Mol Sci"},{"key":"4027_CR2","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R. Comprehensive review on alzheimer\u2019s disease: causes and treatment. Molecules. 2020;25:5789.","journal-title":"Molecules"},{"key":"4027_CR3","doi-asserted-by":"publisher","first-page":"200 e213","DOI":"10.1016\/j.neurobiolaging.2016.02.024","volume":"41","author":"PG Ridge","year":"2016","unstructured":"Ridge PG, Hoyt KB, Boehme K, Mukherjee S, Crane PK, Haines JL, et al. Assessment of the genetic variance of late-onset Alzheimer\u2019s disease. Neurobiol Aging. 2016;41:200 e213\u2013200.e220.","journal-title":"Neurobiol Aging"},{"key":"4027_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397:1577\u201390.","journal-title":"Lancet"},{"key":"4027_CR5","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat Genet. 2021;53:1276\u201382.","journal-title":"Nat Genet"},{"key":"4027_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41582-023-00789-z","volume":"19","author":"C Reitz","year":"2023","unstructured":"Reitz C, Pericak-Vance MA, Foroud T, Mayeux R. A global view of the genetic basis of Alzheimer disease. Nat Rev Neurol. 2023;19:261\u201377.","journal-title":"Nat Rev Neurol"},{"key":"4027_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058618","volume":"8","author":"A Miyashita","year":"2013","unstructured":"Miyashita A, Koike A, Jun G, Wang LS, Takahashi S, Matsubara E, et al. SORL1 is genetically associated with late-onset Alzheimer\u2019s disease in Japanese, Koreans and caucasians. PLoS One. 2013;8:e58618.","journal-title":"PLoS One"},{"key":"4027_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01272-3","volume":"11","author":"D Shigemizu","year":"2021","unstructured":"Shigemizu D, Mitsumori R, Akiyama S, Miyashita A, Morizono T, Higaki S, et al. Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer\u2019s disease risk. Transl Psychiatry. 2021;11:151.","journal-title":"Transl Psychiatry"},{"key":"4027_CR9","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1073\/pnas.1715554115","volume":"115","author":"X Zhou","year":"2018","unstructured":"Zhou X, Chen Y, Mok KY, Zhao Q, Chen K, Chen Y, et al. Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer\u2019s disease pathogenesis. Proc Natl Acad Sci USA. 2018;115:1697\u2013706.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4027_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/brain\/awaa364","volume":"144","author":"L Jia","year":"2021","unstructured":"Jia L, Li F, Wei C, Zhu M, Qu Q, Qin W, et al. Prediction of Alzheimer\u2019s disease using multi-variants from a Chinese genome-wide association study. Brain. 2021;144:924\u201337.","journal-title":"Brain"},{"key":"4027_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01412-9","volume":"11","author":"JH Park","year":"2021","unstructured":"Park JH, Park I, Youm EM, Lee S, Park JH, Lee J, et al. Novel Alzheimer\u2019s disease risk variants identified based on whole-genome sequencing of APOE epsilon4 carriers. Transl Psychiatry. 2021;11:296.","journal-title":"Transl Psychiatry"},{"key":"4027_CR12","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1038\/s41380-022-01483-0","volume":"27","author":"D Shigemizu","year":"2022","unstructured":"Shigemizu D, Asanomi Y, Akiyama S, Mitsumori R, Niida S, Ozaki K. Whole-genome sequencing reveals novel ethnicity-specific rare variants associated with Alzheimer\u2019s disease. Mol Psychiatry. 2022;27:2554\u201362.","journal-title":"Mol Psychiatry"},{"key":"4027_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ajmg.b.32908","volume":"189","author":"D Shigemizu","year":"2022","unstructured":"Shigemizu D, Asanomi Y, Akiyama S, Higaki S, Sakurai T, Ito K, et al. Network-based meta-analysis and the candidate gene association studies reveal novel ethnicity-specific variants in MFSD3 and MRPL43 associated with dementia with Lewy bodies. Am J Med Genet B Neuropsychiatr Genet. 2022;189:139\u201350.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"4027_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"4027_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to alzheimer\u2019s disease: recommendations from the national institute on aging-alzheimer\u2019s association workgroups on diagnostic guidelines for alzheimer\u2019s disease. Alzheimers Dement. 2011;7:270\u20139.","journal-title":"Alzheimers Dement"},{"key":"4027_CR16","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754\u201360.","journal-title":"Bioinformatics"},{"key":"4027_CR17","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment\/map format and SAMtools. Bioinformatics. 2009;25:2078\u20139.","journal-title":"Bioinformatics"},{"key":"4027_CR18","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"4027_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559\u201375.","journal-title":"Am J Hum Genet"},{"key":"4027_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","journal-title":"Nature"},{"key":"4027_CR21","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.","journal-title":"Nucleic Acids Res"},{"key":"4027_CR22","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkad978","volume":"52","author":"S Tadaka","year":"2024","unstructured":"Tadaka S, Kawashima J, Hishinuma E, Saito S, Okamura Y, Otsuki A, et al. jMorp: Japanese multi-omics reference panel update report 2023. Nucleic Acids Res. 2024;52:D622\u201332.","journal-title":"Nucleic Acids Res"},{"key":"4027_CR23","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/biostatistics\/kxs014","volume":"13","author":"S Lee","year":"2012","unstructured":"Lee S, Wu MC, Lin X. Optimal tests for rare variant effects in sequencing association studies. Biostatistics. 2012;13:762\u201375.","journal-title":"Biostatistics"},{"key":"4027_CR24","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/bioinformatics\/btu031","volume":"30","author":"P Jones","year":"2014","unstructured":"Jones P, Binns D, Chang HY, Fraser M, Li W, McAnulla C, et al. InterProScan 5: genome-scale protein function classification. Bioinformatics. 2014;30:1236\u201340.","journal-title":"Bioinformatics"},{"key":"4027_CR25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita M, Schutze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: making protein folding accessible to all. Nat Methods. 2022;19:679\u201382.","journal-title":"Nat Methods"},{"key":"4027_CR26","unstructured":"L S: The PyMOL Molecular Graphics System, Version 1.8. 2015."},{"key":"4027_CR27","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1083\/jcb.201802125","volume":"217","author":"R Dong","year":"2018","unstructured":"Dong R, Zhu T, Benedetti L, Gowrishankar S, Deng H, Cai Y, et al. The inositol 5-phosphatase INPP5K participates in the fine control of ER organization. J Cell Biol. 2018;217:3577\u201392.","journal-title":"J Cell Biol"},{"key":"4027_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41439-019-0059-5","volume":"6","author":"S Tadaka","year":"2019","unstructured":"Tadaka S, Katsuoka F, Ueki M, Kojima K, Makino S, Saito S, et al. 3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome. Hum Genome Var. 2019;6:28.","journal-title":"Hum Genome Var"},{"key":"4027_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1194\/jlr.R087908","volume":"60","author":"AR Ramos","year":"2019","unstructured":"Ramos AR, Ghosh S, Erneux C. The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease. J Lipid Res. 2019;60:276\u201386.","journal-title":"J Lipid Res"},{"key":"4027_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1091\/mbc.e05-05-0469","volume":"17","author":"LM Ooms","year":"2006","unstructured":"Ooms LM, Fedele CG, Astle MV, Ivetac I, Cheung V, Pearson RB, et al. The inositol polyphosphate 5-phosphatase, PIPP, Is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation. Mol Biol Cell. 2006;17:607\u201322.","journal-title":"Mol Biol Cell"},{"key":"4027_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42819-w","volume":"14","author":"V Chou","year":"2023","unstructured":"Chou V, Pearse RV 2nd, Aylward AJ, Ashour N, Taga M, Terzioglu G, et al. INPP5D regulates inflammasome activation in human microglia. Nat Commun. 2023;14. 7552.","journal-title":"Nat Commun"},{"key":"4027_CR32","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1126\/sciadv.abh2169","volume":"7","author":"M Karlsson","year":"2021","unstructured":"Karlsson M, Zhang C, Mear L, Zhong W, Digre A, Katona B, et al. A single-cell type transcriptomics map of human tissues. Sci Adv. 2021;7:1275.","journal-title":"Sci Adv"},{"key":"4027_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ajhg.2017.01.024","volume":"100","author":"M Wiessner","year":"2017","unstructured":"Wiessner M, Roos A, Munn CJ, Viswanathan R, Whyte T, Cox D, et al. Mutations in INPP5K, encoding a phosphoinositide 5-phosphatase, cause congenital muscular dystrophy with cataracts and mild cognitive impairment. Am J Hum Genet. 2017;100:523\u201336.","journal-title":"Am J Hum Genet"},{"key":"4027_CR34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/cge.13143","volume":"93","author":"S Yousaf","year":"2018","unstructured":"Yousaf S, Sheikh SA, Riazuddin S, Waryah AM, Ahmed ZM. INPP5K variant causes autosomal recessive congenital cataract in a Pakistani family. Clin Genet. 2018;93:682\u20136.","journal-title":"Clin Genet"},{"key":"4027_CR35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ajhg.2017.01.019","volume":"100","author":"DPS Osborn","year":"2017","unstructured":"Osborn DPS, Pond HL, Mazaheri N, Dejardin J, Munn CJ, Mushref K, et al. Mutations in INPP5K Cause a form of congenital muscular dystrophy overlapping marinesco-sjogren syndrome and dystroglycanopathy. Am J Hum Genet. 2017;100:537\u201345.","journal-title":"Am J Hum Genet"},{"key":"4027_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.565868","volume":"11","author":"A D\u2019Amico","year":"2020","unstructured":"D\u2019Amico A, Fattori F, Nicita F, Barresi S, Tasca G, Verardo M, et al. A recurrent pathogenic variant of INPP5K underlies autosomal recessive congenital muscular dystrophy with cataracts and intellectual disability: evidence for a founder effect in Southern Italy. Front Genet. 2020;11:565868.","journal-title":"Front Genet"},{"key":"4027_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/bj20030581","volume":"376","author":"S Giuriato","year":"2003","unstructured":"Giuriato S, Pesesse X, Bodin S, Sasaki T, Viala C, Marion E, et al. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels. Biochem J. 2003;376:199\u2013207.","journal-title":"Biochem J"},{"key":"4027_CR38","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136.","journal-title":"Science"},{"key":"4027_CR39","doi-asserted-by":"publisher","first-page":"12990","DOI":"10.3390\/ijms232112990","volume":"23","author":"S Merighi","year":"2022","unstructured":"Merighi S, Nigro M, Travagli A, Gessi S. Microglia and alzheimer\u2019s disease. Int J Mol Sci. 2022;23:12990.","journal-title":"Int J Mol Sci"},{"key":"4027_CR40","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/alz.12821","volume":"19","author":"EL Castranio","year":"2023","unstructured":"Castranio EL, Hasel P, Haure-Mirande JV, Ramirez Jimenez AV, Hamilton BW, Kim RD, et al. Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer\u2019s disease. Alzheimers Dement. 2023;19:2239\u201352.","journal-title":"Alzheimers Dement"},{"key":"4027_CR41","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/alz.12849","volume":"19","author":"PB Lin","year":"2023","unstructured":"Lin PB, Tsai AP, Soni D, Lee-Gosselin A, Moutinho M, Puntambekar SS, et al. INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer\u2019s disease. Alzheimers Dement. 2023;19:2528\u201337.","journal-title":"Alzheimers Dement"},{"key":"4027_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105303","volume":"153","author":"AP Tsai","year":"2021","unstructured":"Tsai AP, Lin PB, Dong C, Moutinho M, Casali BT, Liu Y, et al. INPP5D expression is associated with risk for Alzheimer\u2019s disease and induced by plaque-associated microglia. Neurobiol Dis. 2021;153:105303.","journal-title":"Neurobiol Dis"},{"key":"4027_CR43","doi-asserted-by":"publisher","first-page":"23407","DOI":"10.1074\/jbc.M110.214247","volume":"286","author":"MV Astle","year":"2011","unstructured":"Astle MV, Ooms LM, Cole AR, Binge LC, Dyson JM, Layton MJ, et al. Identification of a proline-rich inositol polyphosphate 5-phosphatase (PIPP)*collapsin response mediator protein 2 (CRMP2) complex that regulates neurite elongation. J Biol Chem. 2011;286:23407\u201318.","journal-title":"J Biol Chem"},{"key":"4027_CR44","doi-asserted-by":"publisher","first-page":"11376","DOI":"10.1074\/jbc.M209991200","volume":"278","author":"R Gurung","year":"2003","unstructured":"Gurung R, Tan A, Ooms LM, McGrath MJ, Huysmans RD, Munday AD, et al. Identification of a novel domain in two mammalian inositol-polyphosphate 5-phosphatases that mediates membrane ruffle localization. The inositol 5-phosphatase skip localizes to the endoplasmic reticulum and translocates to membrane ruffles following epidermal growth factor stimulation. J Biol Chem. 2003;278:11376\u201385.","journal-title":"J Biol Chem"},{"key":"4027_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","volume":"21","author":"R van der Kant","year":"2020","unstructured":"van der Kant R, Goldstein LSB, Ossenkoppele R. Amyloid-beta-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci. 2020;21:21\u201335.","journal-title":"Nat Rev Neurosci"},{"key":"4027_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11357-023-00923-1","volume":"46","author":"L Zadka","year":"2024","unstructured":"Zadka L, Sochocka M, Hachiya N, Chojdak-Lukasiewicz J, Dziegiel P, Piasecki E, et al. Endocytosis and Alzheimer\u2019s disease. Geroscience. 2024;46:71\u201385.","journal-title":"Geroscience"},{"key":"4027_CR47","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1073\/pnas.92.11.4853","volume":"92","author":"X Zhang","year":"1995","unstructured":"Zhang X, Jefferson AB, Auethavekiat V, Majerus PW. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase. Proc Natl Acad Sci USA. 1995;92:4853\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4027_CR48","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nn.2100","volume":"11","author":"DE Berman","year":"2008","unstructured":"Berman DE, Dall\u2019Armi C, Voronov SV, McIntire LB, Zhang H, Moore AZ, et al. Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism. Nat Neurosci. 2008;11:547\u201354.","journal-title":"Nat Neurosci"},{"key":"4027_CR49","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3233\/JAD-140795","volume":"42","author":"SB Martin","year":"2014","unstructured":"Martin SB, Dowling AL, Lianekhammy J, Lott IT, Doran E, Murphy MP, et al. Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer\u2019s disease. J Alzheimers Dis. 2014;42:767\u201375.","journal-title":"J Alzheimers Dis"},{"key":"4027_CR50","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1016\/j.celrep.2018.05.011","volume":"23","author":"AM Miranda","year":"2018","unstructured":"Miranda AM, Herman M, Cheng R, Nahmani E, Barrett G, Micevska E, et al. Excess synaptojanin 1 contributes to place cell dysfunction and memory deficits in the aging hippocampus in three types of alzheimer\u2019s disease. Cell Rep. 2018;23:2967\u201375.","journal-title":"Cell Rep"},{"key":"4027_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1459025","volume":"16","author":"J Pan","year":"2024","unstructured":"Pan J, Yao Q, Wang Y, Chang S, Li C, Wu Y, et al. The role of PI3K signaling pathway in Alzheimer\u2019s disease. Front Aging Neurosci. 2024;16:1459025.","journal-title":"Front Aging Neurosci"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04027-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04027-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04027-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:04:43Z","timestamp":1779167083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04027-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4027"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04027-0","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study protocol was created in accordance with the Declaration of Helsinki and approved by the ethics committee of the NCGG (approval number: 990-16). The design and performance of the current study involving human subjects were clearly described in a research protocol. All methods were performed in accordance with the relevant guidelines and regulations. All participation was voluntary, and participants completed informed consent in writing before registering with the NCGG Biobank.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"267"}}